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Abstract The aim of this study was to compare predic-
tions of hyperbilirubinaemia by eye, performed by
trained physicians and nurses, with predictions obtained
using two commercial bilirubinometers. Jaundice was
assessed in 92 white and 48 non-white healthy full-term
neonates using three non-invasive methods and by total
serum bilirubin as the reference method. Clinical
assessment of cephalocaudal progression of jaundice
was carried out independently by a physician and by
nurses. Simultaneously, the Minolta Airshields JM-102
was applied on the sternum, the BiliCheck on both the
forehead and the sternum, and ﬁnally, serum bilirubin
concentrations were determined. The Minolta JM-102
showed the best performance with r2=0.90, an intraclass
correlation coeﬃcient (ICC) of 0.93, and a 95% conﬁ-
dence interval (CI) of ±4 units (approx. 56 lmol/l). The
BiliCheck performed slightly better on the forehead than
over the sternum with r2=0.90, an ICC of 0.88, and a CI
of ±62 lmol/l. Assessment of jaundice by eye was least
accurate with r2=0.74, an ICC of 0.67, and a CI of ±1.5
zones (corresponding to ±75 lmol/l). Skin pigmenta-
tion and ambient light both adversely aﬀected non-
invasive bilirubin estimation. Conclusion: All three
non-invasive methods are well suited for estimation of
serum bilirubin but show large conﬁdence intervals. In
healthy term newborns, hyperbilirubinaemia (>250
lmol/l) can be safely ruled out by eye if jaundice does
not reach the abdomen or the extremities (Kramer zones
1 and 2), with <22 units (<230 lmol/l) for the Minolta
JM-102, or with a cut-oﬀ of 190 lmol/l for the Bili-
Check. If these respective thresholds are exceeded, serum
bilirubin concentrations should be measured.
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Introduction
Hyperbilirubinaemia, deﬁned as a serum bilirubin
concentration >250 lmol/l, is a frequent problem in
term neonates. As a consequence, serum bilirubin
measurement is the standard method to assess jaun-
diced neonates. It is, unfortunately, invasive, painful,
and costly. To overcome these drawbacks, non-invasive
methods of bilirubin measurement have been proposed.
Since Yamanouchi described a transcutaneous biliru-
binometer in 1980 [22], several devices have been
developed to non-invasively assess serum bilirubin
concentration [16, 17, 21, 22]. These instruments have
been shown to give results that correlate well with
serum bilirubin values, but exhibit large scattering [1].
Consequently, with the application of non-invasive
bilirubinometers, the number of serum measurements
could be reduced and painful heel pricks avoided
but not completely abolished [5, 15]. Warnings have
been published for the use of bilirubinometers in
newborns with dark and yellow skin and in bright
sunlight [23].
The easiest available and cheapest non-invasive
method for assessment of jaundice is the human eye. As
early as 1969, Kramer [13] had published a study which
correlated the clinically observed cephalocaudal
advancement of jaundice with the values of unconju-
gated serum bilirubin. Although in clinical practice the
human eye is used to screen babies for jaundice, this
method has, to our knowledge, not yet been systemati-
cally compared with non-invasive bilirubinometers.
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The aim of our study was therefore to compare the
clinical assessment of jaundice using the method of
Kramer and two methods of transcutaneous bilirubi-
nometry (Minolta JM-102 and BiliCheck) with serum
bilirubin values. The second aim was to investigate the
eﬀect of skin colour and ambient light on the three non-
invasive methods.
Subjects and methods
Patient selection
Full-term healthy newborns, with a birth weight of at
least 2000 g and not older than 6 days, were recruited
from July 1st 2002 until June 30th 2003 in the maternity
ward. Exclusion criteria were: haemolysis, jaundice
within the ﬁrst 36 h, and phototherapy.
Clinical assessment of jaundice
The ﬁve dermal zones of the cephalocaudal progression
of icterus, described by Kramer were used [13]. These
dermal zones and the corresponding ranges of serum
bilirubin values are given in Fig. 1. Jaundice progressing
to zone 5 corresponds to a serum bilirubin of
>250 lmol/l. All infants were assessed independently
by the primary investigator and by the nurse in charge.
The Minolta JM-102 bilirubinometer
The Minolta Airshields JM-102 bilirubinometer is based
on a two-wavelength analysis and gives a reﬂectance unit
(index) [11, 12]. The manufacturer recommends that
each institution establish a conversion table adapted to
its speciﬁc patient mix and reference method. The cor-
responding values obtained in a pilot study are shown in
Table 1. The equation for converting the Minolta JM-
102 index values to units of lmol/l is: y=x·16–124.
Following the manufacturers instructions, two readings
were taken from the sternum and only the higher one
included [7, 12]. Care was taken to avoid skin areas that
were bruised, excessively hairy, or hypermelanotic.
The BiliCheck bilirubinometer
The BiliCheck system averages the spectra of ﬁve repli-
cate measurements at one site to give a bilirubin estimate
in lmol/l (or mg/dl) that is based on reﬂectance data
analysed at multiple wavelengths [2]. Measurements
were performed on the forehead and on the sternum.
Serum bilirubin assay
For each comparison, two samples of 40 ll blood, col-
lected in capillaries from a heel prick, were centrifuged
for 10 min and the serum bilirubin measured with a
Bilimeter II (Pfaﬀ, Neuburg, Germany), a standard
photometer using two wavelengths (455 nm and
575 nm). This instrument was calibrated with test solu-
tions and has a technical error of ±1.3% for values up
to 350 lmol/l. In a previous study, its performance was
compared to HPLC and was shown to correlate well
with HPLC values [17]. The mean value of the two
capillaries was used for comparison.
Study procedure
Before starting the investigation, nurses on the maternity
ward were instructed in the clinical assessment of the
progression of jaundice using the ﬁve dermal zones de-
scribed by Kramer [13]. A nurse routinely checked each
infant for jaundice at intervals no greater than 12 h.
Fig. 1 Correlation between icteric dermal zones (Kramer) and
serum bilirubin values
Table 1 Guide values for the conversion of Minolta JM-102 index
numbers to serum bilirubin equivalents
Index Mean serum bilirubin
equivalent (lmol/l)
Serum bilirubin equivalent
(lmol/l, mean+2SD)
11 52 106
12 68 122
13 84 138
14 100 154
15 116 170
16 132 186
17 148 202
18 164 218
19 180 234
20 196 250
21 213 267
22 229 283
23 245 299
24 261 315
25 277 331
26 293 347
27 309 363
28 325 379
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If jaundice reached the thighs (zone 3), the primary
investigator undertook the same visual assessment of
icterus without knowing the nurse’s result and per-
formed measurements with the two transcutaneous
devices. The ambient light, whether daylight or ﬂuores-
cent light (Osram Lumilux warm white L36 W31) was
recorded. Infants were also included in the study if
jaundice did not reach zone 3 by 72 h; in these infants a
blood sample was taken for bilirubin measurement
together with the routine metabolic screening. Thus, no
additional heel prick was required. For all blood sam-
plings, the nurse administered an oral sweetener for pain
relief [6] before pricking the pre-warmed heel and taking
the two capillary blood samples. Blood sampling
occurred within 10 min after the application of the three
non-invasive methods. The sampled blood was protected
from light and analysed within 30 min.
Data analysis
The statistical analysis was performed using SPSS
(Version 11.5). We compared the diﬀerent methods
(non-invasive measurements versus serum bilirubin)
using linear regression analysis, an intraclass correlation
coeﬃcient (ICC) [14, 18], a Bland-Altman analysis [4],
and receiver operator characteristics (ROC) [10]. The
ICC evaluates the level of agreement between diﬀerent
measurement methods. ICC=1 indicates perfect agree-
ment while ICC=0 indicates no agreement at all. In
contrast to the correlation coeﬃcient (r) of the regres-
sion analysis, the ICC reﬂects systematic diﬀerences
between methods [14]. For example, if one method
always yields double the value of the other method, the
conventional correlation coeﬃcient shows a value of 1,
which reﬂects the perfect linear relation. The ICC for
such an example is, however, smaller than 1 and thus
represents the mismatch. For the Bland-Altman analy-
sis, Kramer zones (Fig. 1) and Minolta units (Table 1)
were converted into lmol/l and the diﬀerence non-
invasive values - serum values’’ plotted against serum
values. This analysis was used to calculate the 95%
conﬁdence intervals (CI) (±2 standard deviations) and
to investigate the inﬂuence of skin colour and ambient
light. To compare the performance of the three non-
invasive tests, sensitivity, speciﬁcity, and the area under
the ROC curve [10] were calculated. The study protocol
was approved by our local ethics committee and
parental consent was obtained for each infant.
Results
Patients
A total of 140 infants born between 37 0/7 and 41 6/7
gestational weeks (median 39 weeks) were included in
this study, of whom 92 were white (caucasian) and 48
were non-white (18 of Asian, 30 of Indian or African
origin). The median birth weight was 3320 g (range
2050–4400 g). Ten infants (7%) were growth retarded
with a birth weight <10th percentile.
Comparison between non-invasive methods
and serum bilirubin
All three non-invasive methods correlated highly with
serum bilirubin (Fig. 2) with the two bilirubinometers
Fig. 2 Results of non-invasive methods plotted against serum
bilirubin values. White infants (open circles), non-white infants
(solid triangles)
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performing better than the clinical assessment. This re-
sult was also conﬁrmed by the intraclass correlation
(Table 2).
The scattering for the Minolta instrument, quantiﬁed
as ±2 SDs or 95% CI, was 4 units (equivalent to
56 lmol/l) for both white and non-white infants. The
BiliCheck showed more variability (P=0.02) in non-
white infants (±68 lmol/l CI) than in white infants
(±52 lmol/l CI) (Fig. 3). Assessments made using the
Kramer method had a 95% CI of ±1.5 zones (corre-
sponding to ±75 lmol/l). The inter-observer agreement
between clinical assessment by nurses and by the phy-
sician was signiﬁcantly (P<0.05) better for white infants
(kappa 0.56) than for non-white infants (kappa 0.36).
Table 3 shows the sensitivity and speciﬁcity for all three
non-invasive methods at various cut-oﬀs for serum bil-
irubin values >250 lmol/l. The area under the ROC-
curve was 0.98 for Minolta, 0.92 for Bilicheck over
forehead, 0.88 for Bilicheck over sternum, and 0.84 for
the Kramer method.
Inﬂuence of the ambient light
The Kramer method and the BiliCheck measurements
over the sternum showed signiﬁcantly less accuracy in
daylight than in white ﬂuorescent light (P<0.001 for
Kramer, P<0.02 for BiliCheck). Measurements per-
formed with the Minolta JM-102 instrument were not
inﬂuenced by ambient light.
Discussion
Our study conﬁrms the previously reported highly sig-
niﬁcant correlation between BiliCheck and Minolta-102
readings with total serum bilirubin values [3, 11, 16, 21].
The correlation of clinical assessment with serum bili-
rubin values for both nurses and the primary investiga-
tor is lower but still statistically signiﬁcant. These
results, based on linear regression analyses, were also
conﬁrmed by ICC, thereby ruling out systematic devia-
tions.
BiliCheck applied to the forehead and clinical
assessment by the physician were signiﬁcantly less
Table 2 Linear correlation coeﬃcients (R2) and ICC for non-
invasive methods compared with serum bilirubin values for white
and non-white infants
Method R2 ICC
White Non-white White Non-white
Kramer (nurse) 0.74 0.71 0.67 0.70
Kramer (paediatrician) 0.70 0.65 0.63 0.44
Minolta sternum 0.90 0.91 0.93 0.92
BiliCheck forehead 0.90 0.87 0.88 0.80
BiliCheck sternum 0.89 0.81 0.89 0.78
Fig. 3 Bland-Altman-Plot: BiliCheck (forehead) in white (open
circles) and non-white infants (solid triangles) versus serum
bilirubin
Table 3 Sensitivity and speciﬁcity for detection of serum bilirubin
>250 lmol/l by the method of Kramer (nurses) and the two
transcutaneous methods (Minolta JM-102) and BiliCheck (on the
forehead)
Sensitivity Speciﬁcity
Kramer nurse (zone) 2 1 0.36
3 0.93 0.46
4 0.84 0.71
5 0.38 0.95
Minolta (index) 19 1 0.44
20 1 0.58
21 1 0.74
22 0.97 0.83
23 0.94 0.94
24 0.66 0.99
BiliCheck forehead (lmol/l) 180 0.97 0.60
190 0.94 0.72
200 0.88 0.80
210 0.84 0.86
220 0.78 0.89
230 0.63 0.94
240 0.59 0.94
250 0.44 0.97
725
accurate in non-white infants than in white infants. The
BiliCheck systematically underestimated serum bilirubin
values by 25 lmol/l on average in non-white (P<0.001)
infants (Fig. 3). This ﬁnding is in contrast with previous
reports and should be investigated further. In the
meantime, caution is indicated with transcutaneous
bilirubinometers in infants with dark skin.
For clinical practice, the speciﬁcity and sensitivity of
a test are considered to be the most useful parameters
for identiﬁcation or exclusion of patients with a disease
(Table 3). As both can be varied—in opposite direc-
tions—by changing the cut-oﬀs, a combined analysis
such as the ROC area is best suited to compare the
performance of a test. In the present study, carried out
in term newborn infants, Minolta had the best perfor-
mance (ROC=0.98), closely followed by BiliCheck over
forehead (ROC=0.92) and over sternum (ROC=0.88),
with clinical assessment providing a weaker, though still
acceptable, performance (ROC=0.84). It should be
noted that the presented results are valid only for term
newborns. We have previously shown that all three
non-invasive test performances were lower in preterm
infants in the range of 34 0/7 to 36 6/7 gestational weeks
[19].
Clinical assessment
Our study conﬁrms the ﬁndings of Kramer [13] who
reported a mean serum bilirubin increase of
50±37 lmol/l (±1 SD) for each dermal zone of jaun-
dice in white and non-white infants. However, a closer
analysis of the relation between dermal zones and serum
bilirubin shows only a small increase of 13 lmol/l from
zone 2 to zone 3. This means that the relation between
these two variables is not linear but S-shaped (Fig. 2).
In our study all infants with jaundice progression
below zone 3 (only head and upper trunk), assessed by
nurses and by the physician, had serum bilirubin below
250 lmol/l. Therefore, for practical purposes this cut-oﬀ
can be used to rule out hyperbilirubinaemia with very
high conﬁdence, eliminating the need to perform further
investigations. In infants with jaundice progression to
zones 3 and 4, the risk for hyperbilirubinaemia is 14%
and 25% respectively. As a consequence, transcutaneous
bilirubinometry or a serum bilirubin measurement
should be performed in these infants.
Minolta JM-102
The Minolta (Airshield) JM-102 showed the best per-
formance of all three non-invasive methods. However,
the inconvenience of having to derive institutional based
calibration factors, adapted to both the population and
the reference method, remains a problem. Our action
guide values were established with white infants
(Table 1) and are approximately the same as those
reported by Wick [20]. However, our reference range is
about 20 lmol/l higher than that published by Harish
and Sharma [11] who investigated a non-white popula-
tion of 60 term newborns in India. The practical con-
sequence from this diﬀerence is that skin pigmentation
aﬀects transcutaneous jaundice assessment.
With its high sensitivity, the Minolta JM-102 biliru-
binometer is ideal for excluding infants without hyper-
bilirubinaemia (<250 lmol/l). This means that infants
with a Minolta index below 22 need not endure a heel
prick for serum bilirubin measurement. Of all infants
with Minolta readings of 23 units or lower, only 6% had
serum bilirubin levels >250 lmol/l and none had a
serum bilirubin >300 lmol/l. Therefore, this cut-oﬀ can
be considered safe provided that transcutaneous mea-
surement is repeated every 4 to 6 h. It should be noted,
however, that this is valid only for healthy term infants
more than 36 h old and not for younger or for sick
infants.
BiliCheck
Our ﬁndings conﬁrm the previously reported good cor-
relation of BiliCheck values with serum bilirubin values
in healthy white term infants [8, 16, 17]. However, in
infants with non-white skin, the BiliCheck instrument
showed a signiﬁcantly lower performance (Fig. 3), with
wider CI and underestimation of serum bilirubin by
25±35 lmol/l, a ﬁnding similar to that already reported
by Engle et al. [9]. Until this ﬁnding has been conﬁrmed
or refuted in a larger patient sample, BiliCheck values
should be interpreted with caution in non-white infants.
In the daily clinical situation, a heel prick can only be
avoided if the BiliCheck shows values below 190 lmol/l
(sensitivity 94%, Table 3).
Another unexpected ﬁnding is the fact that BiliCheck
measurements were aﬀected by ambient light. For Bili-
Check measurements over the sternum, the correlation
with serum bilirubin was signiﬁcantly less accurate with
daylight than with ﬂuorescent room light (P<0.018).
The same tendency was observed over the forehead
(P<0.184). We therefore suggest that transcutaneous
bilirubinometer readings are dependent on the light
conditions under which the measurements are per-
formed. This hypothesis should be tested in a larger
population.
Conclusion
All three non-invasive methods are well suited for esti-
mation of serum bilirubin but have relatively large 95%
CI. Non-invasive measurements may be aﬀected by skin
pigmentation and ambient light. In healty term new-
borns, hyperbilirubinaemia (>250 lmol/l) can be safely
ruled out by eye if jaundice does not reach the abdomen
or the extremities (Kramer zones 1 and 2), with
<22 units (<230 lmol/l) for the Minolta instrument or
with a cut-oﬀ of 190 lmol/l for the BiliCheck system.
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If respective thresholds are exceeded, serum bilirubin
concentration should be measured.
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